DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway
Open Access
- 1 February 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in OncoTargets and Therapy
- Vol. ume 13, 1321-1330
- https://doi.org/10.2147/ott.s239407
Abstract
Background: Clear cell renal cell carcinoma (ccRCC) is one of the most common urologic tumors. However, the carcinogenic mechanism of ccRCC remains unclear. This study aimed to investigate the effects of dual specificity phosphatase 9 (DUSP9) in ccRCC. Methods: Cell proliferation and migration abilities were detected by Cell Counting kit-8, wound-healing (scratch) assay and transwell assay. The expression of mRNA in ccRCC was measured by qPCR. Western blot and immunohistochemical staining were used for protein expression. In addition, nude mouse xenograft experiment establishes an in vivo model to detect the inhibitory effect of DUSP9 on tumor proliferation. Results: DUSP9 was significantly down-regulated in both ccRCC cell lines and ccRCC tissues compared to that in non-cancer cell lines and normal tissues. Besides, DUSP9 suppressed proliferation and migration of ccRCC cell lines in vitro. Importantly, the inhibition of tumor growth by DUSP9 was confirmed by xenograft tumor studies. And DUSP9 could inhibit both phosphorylation of mTOR and expression of its pathway-associated proteins Sox2, c-Myc, and HIF-1α, which are involved in cell proliferation and migration. Conclusion: Taken together, our results uncovered DUSP9 as a tumor suppressor in ccRCC, acting by regulating cell proliferation and migration via the mTOR pathway.Keywords
This publication has 37 references indexed in Scilit:
- Decreased Expression and Prognostic Role of Mitogen-Activated Protein Kinase Phosphatase 4 in Hepatocellular CarcinomaJournal of Gastrointestinal Surgery, 2013
- The Epidemiology of Renal Cell CarcinomaEuropean Urology, 2011
- Decreased expression of dual-specificity phosphatase 9 is associated with poor prognosis in clear cell renal cell carcinomaBMC Cancer, 2011
- Integrated Profiling of MicroRNAs and mRNAs: MicroRNAs Located on Xq27.3 Associate with Clear Cell Renal Cell CarcinomaPLOS ONE, 2010
- Targeted therapies in renal cell cancer: recent developments in imagingTargeted Oncology, 2010
- Targeting mTOR in renal cell carcinomaCancer, 2009
- TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2Cancer Research, 2009
- Dual-specificity MAP kinase phosphatases (MKPs) and cancerCancer and Metastasis Reviews, 2008
- Microtubule Disruption and Tumor Suppression by Mitogen-Activated Protein Kinase Phosphatase 4Cancer Research, 2007
- Molecular Cloning and Functional Characterization of a Novel Mitogen-activated Protein Kinase Phosphatase, MKP-4Online Journal of Public Health Informatics, 1997